Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology
Reference47 articles.
1. Zhao, N., Woodle, M. C., & Mixson, A. J. (2018). Advances in delivery systems for doxorubicin. Journal of Nanomedicine & Nanotechnology, 9, 10. https://doi.org/10.4172/2157-7439.1000519
2. Chatterjee, K., Zhang, J., Honbo, N., & Karliner, J. S. (2010). Doxorubicin cardiomyopathy. Cardiology, 115, 155–162.
3. Mudd, T. W., Jr., Khalid, M., & Guddati, A. K. (2021). Cardiotoxicity of chemotherapy and targeted agents. American Journal of Cancer Research, 11, 1132.
4. Rochette, L., Guenancia, C., Gudjoncik, A., Hachet, O., Zeller, M., Cottin, Y., & Vergely, C. (2015). Anthracyclines/trastuzumab: New aspects of cardiotoxicity and molecular mechanisms. Trends in Pharmacological Sciences, 36, 326–348.
5. Takemura, G., & Fujiwara, H. (2007). Doxorubicin-induced cardiomyopathy: From the cardiotoxic mechanisms to management. Progress in Cardiovascular Diseases, 49, 330–352.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献